Once you see the data, you'll never see patients the same way again

B. Braun's Peripheral Advantage® is a proven program that gives your staff the tools, training and insights they need to confidently deliver consistent PIVC care and a better patient experience. After implementation, program results may include hospital system improvements of clinical, operational and financial outcomes.

Read our latest case study to learn more about how the Peripheral Advantage program improved first-stick success, PIVC dwell times and patient satisfaction at FirstHealth of the Carolinas. As we continue to collect more real world evidence, visit us again to discover how the program can also impact your business. B. Braun—Sharing Expertise.

Download FirstHealth of the Carolinas Case Study

Our Peripheral Advantage® Program can help:

Improve first-stick success

by nearly 14%1

Lengthen PIVC dwell times

to approximately 4.76 days1

Increase patient satisfaction

by more than 10%1

Advantages of the Peripheral Advantage Program

B. Braun’s comprehensive Peripheral Advantage Program combines best-in-class training and curriculum with cutting-edge products and technology. All to help your staff deliver safe and consistent PIVC care.

This program is designed to optimize:

  • Clinical skills & knowledge
  • Clinical outcomes
  • Patient satisfaction
  • Product performance

After implementing B. Braun’s Peripheral Advantage Program at their health system, FirstHealth of the Carolinas reported the following results:

Focusing on better outcomes, right from the first stick

  • PIVC dwell time more than doubled
  • First stick success increased
  • Patient satisfaction improved across multiple campuses
  • PIVC access knowledge increased

Compliance

CA Transparency in Supply Chain Act

CA Proposition 65

Privacy Policy

Terms and Conditions

Terms and Conditions of Sale

© 2022 B. Braun Medical Inc., Bethlehem, PA. All Rights Reserved.

This site is intended for U.S. audiences only. Please consult a product catalog, your sales representative or customer support for product availability. For product usage, please refer to B. Braun product labeling.

1 These are the results of FirstHealth of the Carolinas. Results and clinical experiences may vary by institution.

Address the estimated $1.9 million per year

associated with BSI related to PIVCs2,3

2 Hankins RJ, Selby L. Reducing peripheral venous catheter infections. October 18, 2021. Contagion. 2021;6(5). Accessed September 12, 2022. 
https://www.contagionlive.com/view/reducing-peripheral-venous-catheter-infections

3 Data on file. B. Braun Medical, Inc.